Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 16, 2015 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,000 | $15.27 | 29,659 | |
| Jul 16, 2015 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,000 | -- | -- | |
| Jun 08, 2015 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 4,649 | $16.55 | 26,308 | |
| Jun 08, 2015 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 4,649 | -- | -- | |
| Feb 13, 2015 | SVP, GM - Oncology | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,100 | $15.27 | 46,801 | |
| Feb 13, 2015 | SVP, GM - Oncology | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,100 | -- | -- | |
| Jul 07, 2014 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,000 | $13.18 | 38,357 | |
| Jul 07, 2014 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,000 | -- | -- | |
| May 16, 2014 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,500 | -- | -- | |
| Apr 14, 2014 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,500 | $11.00 | 42,066 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.